Jesús Frías

Also affiliated with Hospital Universitario La Paz

MedicinePharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 7 papers. Top paper: “Smad4-dependent morphogenic signals control the maturation and axonal targeting of basal vomeronasal sensory neurons to the accessory olfactory bulb”.

Smad4-dependent morphogenic signals control the maturation and axonal targeting of basal vomeronasal sensory neurons to the accessory olfactory bulb

Development(2020)10.1242/dev.184036

N/A

0DataRank · unranked

22 citations

Jennifer M. Lin, Ed Zandro M. Taroc, Raghu Ram Katreddi, Jesús Frías, Alex A. Lemus +3 more

Molecular characterization of myotonic dystrophy fibroblast cell lines for use in small molecule screening

iScience(2022)10.1016/j.isci.2022.104198

N/A

0DataRank · unranked

18 citations

Alana O’Brien, Kiril Poukalov, Yidan Lu, Jesús Frías, Hannah K. Shorrock +10 more

Quercetin selectively reduces expanded repeat RNA levels in models of myotonic dystrophy

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.02.02.526846

N/A

0DataRank · unranked

7 citations

Sawyer M Hicks, Jesús Frías, Sweta Vangaveti, Masayuki Nakamori, John D. Cleary +3 more

Alternative splicing dysregulation across tissue and therapeutic approaches in a mouse model of myotonic dystrophy type 1

Molecular Therapy — Nucleic Acids(2024)10.1016/j.omtn.2024.102338

N/A

0DataRank · unranked

9 citations

Jesús Frías, Subodh Kumar Mishra, Marina M. Scotti, Derek R. Muscato, M. Carmen Valero +6 more

Expression levels of core spliceosomal proteins modulate the MBNL-mediated spliceopathy in DM1

Human Molecular Genetics(2024)10.1093/hmg/ddae125

N/A

0DataRank · unranked

3 citations

Jesús Frías, Jacob H Schroader, Lindsey A. Jones, Emily E Davey, Claudia D. Lennon +5 more

Identifying Novel Therapeutics And Modifiers Of Myotonic Dystrophy Type 1

Scholars Archive - University at Albany (University at Albany, State University of New York)(2024)10.54014/ary6-q838

N/A

0DataRank · unranked

0 citations

Jesús Frías

Immunogenicity, Reactogenicity and Safety of a Second Booster with BNT162b2 or Full-Dose mRNA-1273: A Randomised VACCELERATE Trial in Adults ≥75 Years (EU-COVAT-1-AGED Part B)

10.2139/ssrn.4671824

N/A

0DataRank · unranked

0 citations

Lusine Yeghiazaryan, Christoph Stephan, Kirsten Greve-Isdahl Mohn, Antonio J Carcas, Esperanza Romero Rodriguez +35 more